Folate receptor-targeted PEGylated PLGA nanoparticles for the site-specific delivery of hesperidin in epithelial ovarian cancer

Hesperidin (HSP) is a polyphenolic compound employed widely in the therapy of epithelial ovarian cancer (EOC). However, the low bioavailability, attributed to first-pass metabolism, low dissolution and poor tumour specificity, hampered its clinical effectiveness. Therefore, HSP-loaded folic acid-PEG...

Descripción completa

Detalles Bibliográficos

Autores principales:	Rohini Kharwade, Nilesh M. Mahajan, Darshan R. Telange, Priyanka N. Yadav, Sachin R. More
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Taylor & Francis Group 2026-12-01
Colección:	Artificial Cells, Nanomedicine, and Biotechnology
Materias:	Hesperidin PEGylated PLGA nanoparticles folic acid SKOV3 cell line apoptosis
Acceso en línea:	https://www.tandfonline.com/doi/10.1080/21691401.2026.2668273
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!